Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.53 |
| ▸ | RCE1 | Q9Y256 | 4/20 | 0.50 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1826565 | 0.79 | ALDH1A1 (0.50) | LMNAMAPK1 | |
| SCHEMBL4955989 | 0.79 | ALDH1A1 (0.50) | LMNAMAPK1 | |
| SCHEMBL4954667 | 0.79 | ALDH1A1 (0.50) | LMNAMAPK1 | |
| SCHEMBL14376212 | 0.79 | ALDH1A1 (0.50) | LMNAMAPK1 | |
| SCHEMBL28513422 | 0.76 | RCE1 (0.59) | LDHARCE1PTPN22HSP90AA1LMNA | |
| SCHEMBL17540622 | 0.76 | PTPN22 (0.52) | LDHARCE1PTPN22HSP90AA1 | |
| SCHEMBL7210924 | 0.75 | KDM4E (0.54) | LDHAPTPN22LMNAMAPK1 | |
| SCHEMBL11571555 | 0.74 | LMNA (0.50) | LMNAMAPK1 | |
| SCHEMBL9749915 | 0.74 | RCE1 (0.61) | LDHARCE1PTPN22HSP90AA1 | |
| SCHEMBL11526099 | 0.74 | IDO1 (0.50) | LDHALMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8431750-B2 | Preparation of hydroxyaromatic aldehydes | RHODIA OPERATIONS (FR) | 2013-04-30 | — | — | US | claimed |
| US-20110306802-A1 | PREPARATION OF HYDROXYAROMATIC ALDEHYDES | SPECIALTY OPERATIONS FRANCE (FR) | 2011-12-15 | — | — | US | claimed |
| CN-101678333-A | Process for preparing a hydroxyaromatic aldehyde | RHODIA OPERATIONS | 2010-03-24 | — | — | CN | claimed |
| US-4339602-A | Process of preparation of racemic hydroxyarylglycolic acids and novel products resulting therefrom | SOCIETE FRANCAISE HOECHST (FR) | 1982-07-13 | — | — | US | claimed |
| US-8431750-B2 | Preparation of hydroxyaromatic aldehydes | RHODIA OPERATIONS (FR) | 2013-04-30 | — | — | US | disclosed |
| US-20110306802-A1 | PREPARATION OF HYDROXYAROMATIC ALDEHYDES | SPECIALTY OPERATIONS FRANCE (FR) | 2011-12-15 | — | — | US | disclosed |
| CN-101678333-A | Process for preparing a hydroxyaromatic aldehyde | RHODIA OPERATIONS | 2010-03-24 | — | — | CN | disclosed |
| US-4339602-A | Process of preparation of racemic hydroxyarylglycolic acids and novel products resulting therefrom | SOCIETE FRANCAISE HOECHST (FR) | 1982-07-13 | — | — | US | disclosed |
| US-4339602-A | Process of preparation of racemic hydroxyarylglycolic acids and novel products resulting therefrom | SOCIETE FRANCAISE HOECHST (FR) | 1982-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306802-A1 | PREPARATION OF HYDROXYAROMATIC ALDEHYDES | AOX1, ALDH2, ALDH1A1 | LDHA 57/4885RCE1 824/4885PTPN22 4239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.